Is advanced esophageal adenocarcinoma a distinct entity from intestinal subtype gastric cancer? Data from the AGAMENON-SEOM Registry

被引：0
|
作者：
Felipe Alvarez-Manceñido
Paula Jimenez-Fonseca
Alberto Carmona-Bayonas
Virginia Arrazubi
Raquel Hernandez
Juana M. Cano
Ana Custodio
Carles Pericay Pijaume
Gema Aguado
Nieves Martínez Lago
Manuel Sánchez Cánovas
Diego Cacho Lavin
Laura Visa
Alba Martinez-Torron
Aranzazu Arias-Martinez
Flora López
M. Luisa Limón
Rosario Vidal Tocino
Ana Fernández Montes
Maria Alsina
Paola Pimentel
Pablo Reguera
Alfonso Martín Carnicero
Avinash Ramchandani
Mónica Granja
Aitor Azkarate
Marta Martín Richard
Olbia Serra
Carolina Hernández Pérez
Alicia Hurtado
Aitziber Gil-Negrete
Tamara Sauri
Patricia Morales del Burgo
Javier Gallego
机构：
[1] Hospital Universitario Central de Asturias,Pharmacy Department
[2] Hospital Universitario Central de Asturias,Medical Oncology Department
[3] ISPA,Hematology and Medical Oncology Department
[4] Hospital Universitario Morales Meseguer,Medical Oncology Department
[5] University of Murcia,Medical Oncology Department
[6] IMIB,Medical Oncology Department
[7] Complejo Hospitalario de Navarra,Medical Oncology Department
[8] Hospital Universitario de Canarias,Medical Oncology Department
[9] Hospital General Universitario de Ciudad Real,Medical Oncology Department
[10] Hospital Universitario La Paz,Medical Oncology Department
[11] CIBERONC CB16/12/00398,Hematology and Medical Oncology Department
[12] Hospital Universitario Parc Tauli,Medical Oncology Department
[13] Hospital Universitario Gregorio Marañón,Medical Oncology Department
[14] Complejo Hospitalario Universitario de A Coruña,Pharmacy Department
[15] Hospital Universitario Morales Meseguer,Medical Oncology Department
[16] Hospital Universitario Marqués de Valdecilla,Medical Oncology Department
[17] IDIVAL,Medical Oncology Department
[18] Hospital Universitario El Mar,Medical Oncology Department
[19] Hospital Universitario Marqués de Valdecilla,Medical Oncology Department
[20] Hospital Universitario Doce de Octubre,Medical Oncology Department
[21] Hospital Universitario Virgen del Rocío,Medical Oncology Department
[22] Complejo Asistencial Universitario de Salamanca-IBSAL,Medical Oncology Department
[23] Complejo Hospitalario de Orense,Medical Oncology Department
[24] Hospital Universitario Vall d’Hebron,Medical Oncology Department
[25] Vall Hebron Institute of Oncology (VHIO),Medical Oncology Department
[26] Hospital General Universitario Santa Lucía,Medical Oncology Department
[27] Hospital Universitario Ramón y Cajal,Medical Oncology Department
[28] Hospital San Pedro,Medical Oncology Department
[29] Hospital Universitario Insular de Gran Canaria,Medical Oncology Department
[30] Hospital Universitario Clínico San Carlos,Medical Oncology Department
[31] Hospital Universitario Son Espases,Medical Oncology Department
[32] Hospital Universitario Santa Creu i Sant Pau,Pathology Department
[33] Catalan Institute of Oncology,Medical Oncology Department
[34] Hospital Universitario Nuestra Señora de la Candelaria,undefined
[35] Hospital Universitario Fundación Alcorcón,undefined
[36] Hospital Universitario Donostia,undefined
[37] Hospital Clinic,undefined
[38] IDIBAPS,undefined
[39] Hospital Universitario Central de Asturias,undefined
[40] Hospital General Universitario de Elche,undefined
来源：
Gastric Cancer | 2021年 / 24卷
关键词：
Esophageal adenocarcinoma; Chemotherapy; Gastric cancer; Gastroesophageal junction; Trastuzumab; Survival; Prognosis; Advanced cancer; Lauren type; Erbb;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：926 / 936
页数：10
相关论文
共 50 条
  • [1] Is advanced esophageal adenocarcinoma a distinct entity from intestinal subtype gastric cancer? Data from the AGAMENON-SEOM Registry
    Alvarez-Mancenido, Felipe
    Jimenez-Fonseca, Paula
    Carmona-Bayonas, Alberto
    Arrazubi, Virginia
    Hernandez, Raquel
    Cano, Juana M.
    Custodio, Ana
    Pericay Pijaume, Carles
    Aguado, Gema
    Martinez Lago, Nieves
    Sanchez Canovas, Manuel
    Cacho Lavin, Diego
    Visa, Laura
    Martinez-Torron, Alba
    Arias-Martinez, Aranzazu
    Lopez, Flora
    Limon, M. Luisa
    Vidal Tocino, Rosario
    Fernandez Montes, Ana
    Alsina, Maria
    Pimentel, Paola
    Reguera, Pablo
    Martin Carnicero, Alfonso
    Ramchandani, Avinash
    Granja, Monica
    Azkarate, Aitor
    Martin Richard, Marta
    Serra, Olbia
    Hernandez Perez, Carolina
    Hurtado, Alicia
    Gil-Negrete, Aitziber
    Sauri, Tamara
    Morales del Burgo, Patricia
    Gallego, Javier
    GASTRIC CANCER, 2021, 24 (04) : 926 - 936
  • [2] Identification of Thrombosis-Related Genes in Patients with Advanced Gastric Cancer: Data from AGAMENON-SEOM Registry
    Zaragoza-Huesca, David
    Garrido-Rodriguez, Pedro
    Jimenez-Fonseca, Paula
    Martinez de Castro, Eva
    Sanchez-Canovas, Manuel
    Visa, Laura
    Custodio, Ana
    Fernandez-Montes, Ana
    Penas-Martinez, Julia
    Morales del Burgo, Patricia
    Gallego, Javier
    Luengo-Gil, Gines
    Vicente, Vicente
    Martinez-Martinez, Irene
    Carmona-Bayonas, Alberto
    BIOMEDICINES, 2022, 10 (01)
  • [3] Sex and gender disparities in patients with advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registry
    Gallego Plazas, J.
    Arias-Martinez, A.
    Lecumberri, A.
    Martinez de Castro, E.
    Custodio, A.
    Cano, J. M.
    Hernandez, R.
    Montes, A. F.
    Macias, I
    Pieras-Lopez, A.
    Diez, M.
    Visa, L.
    Tocino, R., V
    Martinez Lago, N.
    Limon, M. L.
    Gil, M.
    Pimentel, P.
    Mangas, M.
    Granja, M.
    Carnicero, A. M.
    Hernandez Perez, C.
    Gonzalez, L. G.
    Jimenez-Fonseca, P.
    Carmona-Bayonas, A.
    ESMO OPEN, 2022, 7 (03)
  • [4] Efficacy and safety of chemotherapy in young patients with advanced gastroesophageal adenocarcinoma: data from the Spanish AGAMENON-SEOM registry
    Perez-Wert, Pablo
    Custodio, Ana
    Jimenez-Fonseca, Paula
    Carmona-Bayonas, Alberto
    Lecumberri, Arturo
    Cacho Lavin, Diego
    Losantos Garcia, Itsaso
    Fernandez Montes, Ana
    Cano, Juana Maria
    Limon, Maria Luisa
    Hernandez San Gil, Raquel
    Diez, Marc
    Vidal Tocino, Rosario
    Macias Declara, Ismael
    Visa, Laura
    Pimentel Caceres, Paola
    Gil Raga, Mireia
    Martinez Moreno, Elia
    Sauri, Tamara
    Martin Richard, Marta
    Granja, Monica
    Cerda, Paula
    Gomez Gonzalez, Lucia
    Merida-Garcia, Antonio
    Ruiz Martin, Maribel
    Gallego, Javier
    GASTRIC CANCER, 2024, 27 (01) : 131 - 145
  • [5] External validity of clinical trials with diverse trastuzumab-based chemotherapy regimens in advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registry
    Jimenez-Fonseca, Paula
    Carmona-Bayonas, Alberto
    Martinez-Torron, Alba
    Alsina, Maria
    Custodio, Ana
    Serra, Olbia
    Cacho Lavin, Diego
    Limon, Maria Luisa
    Sauri, Tamara
    Lopez, Flora
    Visa, Laura
    Granja, Monica
    Martinez Lago, Nieves
    Arrazubi, Virginia
    Vidal Tocino, Rosario
    Hernandez, Raquel
    Aguado, Gema
    Cano, Juana Maria
    Martin Carnicero, Alfonso
    Mangas, Monserrat
    Pimentel, Paola
    Fernandez Montes, Ana
    Macias Declara, Ismael
    Longo, Federico
    Ramchandani, Avinash
    Martin Richard, Marta
    Hurtado, Alicia
    Azkarate, Aitor
    Hernandez Perez, Carolina
    Serrano, Raquel
    Gallego, Javier
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [6] Does HER2 status influence in the benefit of ramucirumab and paclitaxel as second line treatment of advanced gastro-esophageal adenocarcinoma? Data from the AGAMENON-SEOM registry
    Valcarcel, Sena
    Gallego, Javier
    Jimenez-Fonseca, Paula
    Diez, Marc
    Martinez de Castro, Eva
    Hernandez, Raquel
    Arrazubi, Virginia
    Custodio, Ana
    Maria Cano, Juana
    Fernandez Montes, Ana
    Macias, Ismael
    Visa, Laura
    Calvo, Aitana
    Vidal Tocino, Rosario
    Martinez Lago, Nieves
    Luisa Limon, Maria
    Granja, Monica
    Gil, Mireia
    Pimentel, Paola
    Macia-Rivas, Lola
    Perez, Carolina Hernandez
    Mangas, Montserrat
    Martin Carnicero, Alfonso
    Cerda, Paula
    Gomez Gonzalez, Lucia
    Garcia Navalon, Francisco
    Mediano Rambla, Ma Dolores
    Martin Richard, Marta
    Carmona-Bayonas, Alberto
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (07) : 4077 - 4089
  • [7] Does HER2 status influence in the benefit of ramucirumab and paclitaxel as second line treatment of advanced gastro-esophageal adenocarcinoma? Data from the AGAMENON-SEOM registry
    Sena Valcarcel
    Javier Gallego
    Paula Jimenez-Fonseca
    Marc Diez
    Eva Martínez de Castro
    Raquel Hernandez
    Virginia Arrazubi
    Ana Custodio
    Juana María Cano
    Ana Fernández Montes
    Ismael Macias
    Laura Visa
    Aitana Calvo
    Rosario Vidal Tocino
    Nieves Martínez Lago
    María Luisa Limón
    Mónica Granja
    Mireia Gil
    Paola Pimentel
    Lola Macia-Rivas
    Carolina Hernández Pérez
    Montserrat Mangas
    Alfonso Martín Carnicero
    Paula Cerdà
    Lucía Gomez Gonzalez
    Francisco Garcia Navalon
    Mª Dolores Mediano Rambla
    Marta Martin Richard
    Alberto Carmona-Bayonas
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 4077 - 4089
  • [8] Is there a preferred platinum and fluoropyrimidine regimen for advanced HER2-negative esophagogastric adenocarcinoma? Insights from 1293 patients in AGAMENON-SEOM registry
    Arias-Martinez, Aranzazu
    de Castro, Eva Martinez
    Gallego, Javier
    Arrazubi, Virginia
    Custodio, Ana
    Fernandez Montes, Ana
    Diez, Marc
    Hernandez, Raquel
    Limon, Maria Luisa
    Cano, Juana Maria
    Vidal-Tocino, Rosario
    Macias, Ismael
    Visa, Laura
    Martin Richard, Marta
    Sauri, Tamara
    Hierro, Cinta
    Gil, Mireia
    Cerda, Paula
    Martinez Moreno, Elia
    Martinez Lago, Nieves
    Merida-Garcia, Antonio Jose
    Gomez Gonzalez, Lucia
    Garcia Navalon, Francisco Javier
    Ruiz Martin, Maribel
    Marin, Gema
    Lopez-Lopez, Flora
    Ruperez Blanco, Ana Belen
    Fernandez, Alejandro Francisco
    Jimenez-Fonseca, Paula
    Carmona-Bayonas, Alberto
    Alvarez-Mancenido, Felipe
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (07) : 1674 - 1686
  • [9] Surgery for metastases for esophageal-gastric cancer in the real world: Data from the AGAMENON national registry
    Carmona-Bayonas, Alberto
    Jimenez-Fonseca, Paula
    Echavarria, Isabel
    Sanchez Canovas, Manuel
    Aguado, Gema
    Gallego, Javier
    Custodio, Ana
    Hernandez, Raquel
    Viudez, Antonio
    Maria Cano, Juana
    Martinez de Castro, Eva
    Macias, Ismael
    Carnicero, Alfonso Martin
    Garrido, Marcelo
    Mangas, Monserrat
    Alvarez Mancenido, Felipe
    Visa, Laura
    Azkarate, Aitor
    Ramchandani, Avinash
    Fernandez Montes, Ana
    Longo, Federico
    Sanchez, Ana
    Pimentel, Paola
    Luisa Limon, Maria
    Arias, David
    Cacho Lavin, Diego
    Sanchez Bayona, Rodrigo
    Cerda, Paula
    Garcia Alfonso, Pilar
    EJSO, 2018, 44 (08): : 1191 - 1198
  • [10] Second-line treatment in advanced gastric cancer: Data from the Spanish AGAMENON registry
    Cotes Sanchis, Almudena
    Gallego, Javier
    Hernandez, Raquel
    Arrazubi, Virginia
    Custodio, Ana
    Maria Cano, Juana
    Aguado, Gema
    Macias, Ismael
    Lopez, Carlos
    Lopez, Flora
    Visa, Laura
    Garrido, Marcelo
    Martinez Lago, Nieves
    Fernandez Montes, Ana
    Luisa Limon, Maria
    Azkarate, Aitor
    Pimentel, Paola
    Reguera, Pablo
    Ramchandani, Avinash
    Diego Cacho, Juan
    Martin Carnicero, Alfonso
    Granja, Monica
    Martin Richard, Marta
    Hernandez Perez, Carolina
    Hurtado, Alicia
    Serra, Olbia
    Buxo, Elvira
    Vidal Tocino, Rosario
    Jimenez-Fonseca, Paula
    Carmona-Bayonas, Alberto
    PLOS ONE, 2020, 15 (07):
12345